Results 21 to 30 of about 131,375 (266)

Coronavirus-19 infection in kidney transplant recipients: A comprehensive review

Indian Journal of Urology, 2022
The COVID-19 pandemic has disrupted health care across the globe. Since the beginning of the pandemic, there have been substantial changes in the approach toward kidney transplantation and management of the virus in transplant recipients.
Gina DeFelice, Adarsh Vijay
doaj   +1 more source

Tuberculosis in Renal Transplant Recipients

Renal Failure, 2011
Renal transplant recipients should be considered at high risk for development of Mycobacterium tuberculosis infection (tuberculosis, TB). TB is relatively more frequent among transplant recipients than general population, depending on its epidemicity in the geographic region. Clinical manifestations in this group of patients may be atypical and deserve
Celik, Ali, SOYLU, ALPER, ÇAVDAR, CANER, BORA, SEYMEN, ATİLA, KORAY, Camsari, Taner, Gulay, Huseyin, Sifil, Aykut, Ersan, Sibel   +8 more
openaire   +4 more sources

Ehrlichiosis and Anaplasmosis among Transfusion and Transplant Recipients in the United States

Emerging Infectious Diseases, 2021
Ehrlichiosis and anaplasmosis are emerging tickborne diseases that can also be transmitted through blood transfusions or organ transplants. Since 2000, ehrlichiosis and anaplasmosis cases in the United States have increased substantially, resulting in ...
Sanjida J. Mowla, Naomi A. Drexler, Cara C. Cherry, Pallavi D. Annambholta, Ian T. Kracalik, Sridhar V. Basavaraju   +5 more
doaj   +1 more source

Invasive Aspergillosis in Transplant Recipients

Medicine, 1999
Infections and rejection have long been the leading causes of morbidity and mortality in transplant recipients. Although recent advances in immunosuppression, prophylaxis, and treatment of infections such as cytomegalovirus have resulted in improved outcome in transplant recipients, invasive aspergillosis remains a scourge of transplantation medicine ...
Paterson, David L., Singh, Nina
openaire   +5 more sources

Fungal infections in transplant recipients [PDF]

European Respiratory Journal, 2001
Fungi are ubiquitous and the respiratory tract is exposed to aerosolized spores of both fungi that are “pathogenic” even in the normal host, such asCryptococus neoformans, and those that are “opportunistic”, such asCandidaandAspergillusspecies, among others.
Nicod LP, Pache JC, Howarth N
openaire   +3 more sources

Hypertension in thoracic transplant recipients [PDF]

Journal of Human Hypertension, 1998
There are many mechanisms underlying the hypertension which occurs after thoracic transplantation. Previous disease, effects of cyclosporin, tacrolimus and steroid immunosuppression and cardiac denervation are major contributory factors. Abnormal sodium and water balance is an important common mediating factor.
G H, Jenkins, D R, Singer
openaire   +2 more sources

Immunosuppression after the diagnosis of renal allograft renal cell carcinoma in two transplant recipients: Case reports and review of the literature

Indian Journal of Transplantation, 2021
Renal cell carcinoma (RCC) is a common solid malignancy among renal transplant recipients. While it commonly involves the native kidneys, renal allograft RCC is increasingly being reported in renal transplant recipients.
Joyita Bharati, Parikshaa Gupta, Ujjwal Gorsi, Ravimohan S Mavuduru, Vivek Kumar, Manish Rathi, Harbir Singh Kohli, Raja Ramachandran   +7 more
doaj   +1 more source

Changes in quality of life (QoL) and other patient-reported outcome measures (PROMs) in living-donor and deceased-donor kidney transplant recipients and those awaiting transplantation in the UK ATTOM programme: a longitudinal cohort questionnaire survey with additional qualitative interviews

BMJ Open, 2021
Objective To examine quality of life (QoL) and other patient-reported outcome measures (PROMs) in kidney transplant recipients and those awaiting transplantation.Design Longitudinal cohort questionnaire surveys and qualitative semi-structured interviews ...
Paul Roderick, Christopher Dudley, Heather Draper, Clare Bradley, Gabriel C Oniscu, Andrea Gibbons, Marco Cinnirella, Janet Bayfield, Rachel J Johnson, John L R Forsythe, Wendy Metcalfe, Rommel Ravanan, Christopher J E Watson, J Andrew Bradley, Charles Tomson   +14 more
doaj   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker, Kyle Kemp, Perri Tutelman, Sharon H. J. Hou, Paul Fairie, Maria Santana, Gregory M. T. Guilcher, Taryn Fay‐McClymont, Glenda Bendiak, Wendy Pelletier, Nicola Wright, Fiona Schulte   +11 more
wiley   +1 more source